1 Veterinary Vaccination Market Overview

• 1.1 Product Overview and Scope of Veterinary Vaccination
• 1.2 Veterinary Vaccination Segment by Type
• 1.2.1 Global Veterinary Vaccination Sales Growth Rate Comparison by Type (2022-2028)

1.2.2 Live Attenuated Vaccines

1.2.3 Inactivated Vaccines

1.2.4 Other

1.3 Veterinary Vaccination Segment by Application

1.3.1 Global Veterinary Vaccination Sales Comparison by Application: (2022-2028)

1.3.2 Livestock

1.3.3 Swine

1.3.4 Chicken

1.3.5 Dog & Cat

1.3.6 Other

1.4 Global Veterinary Vaccination Market Size Estimates and Forecasts

1.4.1 Global Veterinary Vaccination Revenue 2017-2028

1.4.2 Global Veterinary Vaccination Sales 2017-2028

1.4.3 Veterinary Vaccination Market Size by Region: 2017 Versus 2021 Versus 2028

2 Veterinary Vaccination Market Competition by Manufacturers

• 2.1 Global Veterinary Vaccination Sales Market Share by Manufacturers (2017-2022)
• 2.2 Global Veterinary Vaccination Revenue Market Share by Manufacturers (2017-2022)
• 2.3 Global Veterinary Vaccination Average Price by Manufacturers (2017-2022)
• 2.4 Manufacturers Veterinary Vaccination Manufacturing Sites, Area Served, Product Type
• 2.5 Veterinary Vaccination Market Competitive Situation and Trends
• 2.5.1 Veterinary Vaccination Market Concentration Rate

2.5.2 The Global Top 5 and Top 10 Largest Veterinary Vaccination Players Market Share by Revenue

2.5.3 Global Veterinary Vaccination Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Veterinary Vaccination Retrospective Market Scenario by Region

• 3.1 Global Veterinary Vaccination Retrospective Market Scenario in Sales by Region: 2017-2022
• 3.2 Global Veterinary Vaccination Retrospective Market Scenario in Revenue by Region: 2017-2022
• 3.3 North America Veterinary Vaccination Market Facts & Figures by Country
• 3.3.1 North America Veterinary Vaccination Sales by Country

3.3.2 North America Veterinary Vaccination Revenue by Country

3.3.3 United States

3.3.4 Canada

3.4 Europe Veterinary Vaccination Market Facts & Figures by Country

3.4.1 Europe Veterinary Vaccination Sales by Country

3.4.2 Europe Veterinary Vaccination Revenue by Country

3.4.3 Germany

3.4.4 France

3.4.5 U.K.

3.4.6 Italy

3.4.7 Russia

3.5 Asia Pacific Veterinary Vaccination Market Facts & Figures by Region

3.5.1 Asia Pacific Veterinary Vaccination Sales by Region

3.5.2 Asia Pacific Veterinary Vaccination Revenue by Region

3.5.3 China

3.5.4 Japan

3.5.5 South Korea

3.5.6 India

3.5.7 Australia

3.5.8 China Taiwan

3.5.9 Indonesia

3.5.10 Thailand

3.5.11 Malaysia

3.6 Latin America Veterinary Vaccination Market Facts & Figures by Country

3.6.1 Latin America Veterinary Vaccination Sales by Country

3.6.2 Latin America Veterinary Vaccination Revenue by Country

3.6.3 Mexico

3.6.4 Brazil

3.6.5 Argentina

3.7 Middle East and Africa Veterinary Vaccination Market Facts & Figures by Country

3.7.1 Middle East and Africa Veterinary Vaccination Sales by Country

3.7.2 Middle East and Africa Veterinary Vaccination Revenue by Country

3.7.3 Turkey

3.7.4 Saudi Arabia

3.7.5 UAE

4 Global Veterinary Vaccination Historic Market Analysis by Type

• 4.1 Global Veterinary Vaccination Sales Market Share by Type (2017-2022)
• 4.2 Global Veterinary Vaccination Revenue Market Share by Type (2017-2022)
• 4.3 Global Veterinary Vaccination Price by Type (2017-2022)

5 Global Veterinary Vaccination Historic Market Analysis by Application

• 5.1 Global Veterinary Vaccination Sales Market Share by Application (2017-2022)
• 5.2 Global Veterinary Vaccination Revenue Market Share by Application (2017-2022)
• 5.3 Global Veterinary Vaccination Price by Application (2017-2022)

6 Key Companies Profiled

• 6.1 Merck
• 6.1.1 Merck Corporation Information

6.1.2 Merck Description and Business Overview

6.1.3 Merck Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.1.4 Merck Veterinary Vaccination Product Portfolio

6.1.5 Merck Recent Developments/Updates

6.2 Zoetis

6.2.1 Zoetis Corporation Information

6.2.2 Zoetis Description and Business Overview

6.2.3 Zoetis Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.2.4 Zoetis Veterinary Vaccination Product Portfolio

6.2.5 Zoetis Recent Developments/Updates

6.3 Boehringer Ingelheim

6.3.1 Boehringer Ingelheim Corporation Information

6.3.2 Boehringer Ingelheim Description and Business Overview

6.3.3 Boehringer Ingelheim Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.3.4 Boehringer Ingelheim Veterinary Vaccination Product Portfolio

6.3.5 Boehringer Ingelheim Recent Developments/Updates

6.4 Ceva

6.4.1 Ceva Corporation Information

6.4.2 Ceva Description and Business Overview

6.4.3 Ceva Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Ceva Veterinary Vaccination Product Portfolio

6.4.5 Ceva Recent Developments/Updates

6.5 CAHIC

6.5.1 CAHIC Corporation Information

6.5.2 CAHIC Description and Business Overview

6.5.3 CAHIC Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.5.4 CAHIC Veterinary Vaccination Product Portfolio

6.5.5 CAHIC Recent Developments/Updates

6.6 HVRI

6.6.1 HVRI Corporation Information

6.6.2 HVRI Description and Business Overview

6.6.3 HVRI Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.6.4 HVRI Veterinary Vaccination Product Portfolio

6.6.5 HVRI Recent Developments/Updates

6.7 Ringpu Biology

6.6.1 Ringpu Biology Corporation Information

6.6.2 Ringpu Biology Description and Business Overview

6.6.3 Ringpu Biology Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.4.4 Ringpu Biology Veterinary Vaccination Product Portfolio

6.7.5 Ringpu Biology Recent Developments/Updates

6.8 Yebio

6.8.1 Yebio Corporation Information

6.8.2 Yebio Description and Business Overview

6.8.3 Yebio Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.8.4 Yebio Veterinary Vaccination Product Portfolio

6.8.5 Yebio Recent Developments/Updates

6.9 DHN

6.9.1 DHN Corporation Information

6.9.2 DHN Description and Business Overview

6.9.3 DHN Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.9.4 DHN Veterinary Vaccination Product Portfolio

6.9.5 DHN Recent Developments/Updates

6.10 WINSUN

6.10.1 WINSUN Corporation Information

6.10.2 WINSUN Description and Business Overview

6.10.3 WINSUN Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.10.4 WINSUN Veterinary Vaccination Product Portfolio

6.10.5 WINSUN Recent Developments/Updates

6.11 Elanco

6.11.1 Elanco Corporation Information

6.11.2 Elanco Veterinary Vaccination Description and Business Overview

6.11.3 Elanco Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.11.4 Elanco Veterinary Vaccination Product Portfolio

6.11.5 Elanco Recent Developments/Updates

6.12 Virbac

6.12.1 Virbac Corporation Information

6.12.2 Virbac Veterinary Vaccination Description and Business Overview

6.12.3 Virbac Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.12.4 Virbac Veterinary Vaccination Product Portfolio

6.12.5 Virbac Recent Developments/Updates

6.13 Jinyu Bio-Technology

6.13.1 Jinyu Bio-Technology Corporation Information

6.13.2 Jinyu Bio-Technology Veterinary Vaccination Description and Business Overview

6.13.3 Jinyu Bio-Technology Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.13.4 Jinyu Bio-Technology Veterinary Vaccination Product Portfolio

6.13.5 Jinyu Bio-Technology Recent Developments/Updates

6.14 ChengDu Tecbond

6.14.1 ChengDu Tecbond Corporation Information

6.14.2 ChengDu Tecbond Veterinary Vaccination Description and Business Overview

6.14.3 ChengDu Tecbond Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.14.4 ChengDu Tecbond Veterinary Vaccination Product Portfolio

6.14.5 ChengDu Tecbond Recent Developments/Updates

6.15 CAVAC

6.15.1 CAVAC Corporation Information

6.15.2 CAVAC Veterinary Vaccination Description and Business Overview

6.15.3 CAVAC Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.15.4 CAVAC Veterinary Vaccination Product Portfolio

6.15.5 CAVAC Recent Developments/Updates

6.16 Kyoto Biken Laboratories

6.16.1 Kyoto Biken Laboratories Corporation Information

6.16.2 Kyoto Biken Laboratories Veterinary Vaccination Description and Business Overview

6.16.3 Kyoto Biken Laboratories Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.16.4 Kyoto Biken Laboratories Veterinary Vaccination Product Portfolio

6.16.5 Kyoto Biken Laboratories Recent Developments/Updates

6.17 FATRO

6.17.1 FATRO Corporation Information

6.17.2 FATRO Veterinary Vaccination Description and Business Overview

6.17.3 FATRO Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.17.4 FATRO Veterinary Vaccination Product Portfolio

6.17.5 FATRO Recent Developments/Updates

6.18 Vaksindo

6.18.1 Vaksindo Corporation Information

6.18.2 Vaksindo Veterinary Vaccination Description and Business Overview

6.18.3 Vaksindo Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.18.4 Vaksindo Veterinary Vaccination Product Portfolio

6.18.5 Vaksindo Recent Developments/Updates

6.19 Bio-Labs

6.19.1 Bio-Labs Corporation Information

6.19.2 Bio-Labs Veterinary Vaccination Description and Business Overview

6.19.3 Bio-Labs Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.19.4 Bio-Labs Veterinary Vaccination Product Portfolio

6.19.5 Bio-Labs Recent Developments/Updates

6.20 Avimex Animal Health

6.20.1 Avimex Animal Health Corporation Information

6.20.2 Avimex Animal Health Veterinary Vaccination Description and Business Overview

6.20.3 Avimex Animal Health Veterinary Vaccination Sales, Revenue and Gross Margin (2017-2022)

6.20.4 Avimex Animal Health Veterinary Vaccination Product Portfolio

6.20.5 Avimex Animal Health Recent Developments/Updates

7 Veterinary Vaccination Manufacturing Cost Analysis

• 7.1 Veterinary Vaccination Key Raw Materials Analysis
• 7.1.1 Key Raw Materials

7.1.2 Key Suppliers of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.3 Manufacturing Process Analysis of Veterinary Vaccination

7.4 Veterinary Vaccination Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers

• 8.1 Marketing Channel
• 8.2 Veterinary Vaccination Distributors List
• 8.3 Veterinary Vaccination Customers

9 Veterinary Vaccination Market Dynamics

• 9.1 Veterinary Vaccination Industry Trends
• 9.2 Veterinary Vaccination Market Drivers
• 9.3 Veterinary Vaccination Market Challenges
• 9.4 Veterinary Vaccination Market Restraints

10 Global Market Forecast

• 10.1 Veterinary Vaccination Market Estimates and Projections by Type
• 10.1.1 Global Forecasted Sales of Veterinary Vaccination by Type (2023-2028)

10.1.2 Global Forecasted Revenue of Veterinary Vaccination by Type (2023-2028)

10.2 Veterinary Vaccination Market Estimates and Projections by Application

10.2.1 Global Forecasted Sales of Veterinary Vaccination by Application (2023-2028)

10.2.2 Global Forecasted Revenue of Veterinary Vaccination by Application (2023-2028)

10.3 Veterinary Vaccination Market Estimates and Projections by Region

10.3.1 Global Forecasted Sales of Veterinary Vaccination by Region (2023-2028)

10.3.2 Global Forecasted Revenue of Veterinary Vaccination by Region (2023-2028)

11 Research Finding and Conclusion

12 Methodology and Data Source

• 12.1 Methodology/Research Approach
• 12.1.1 Research Programs/Design

12.1.2 Market Size Estimation

12.1.3 Market Breakdown and Data Triangulation

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Author List

Vaccines are products designed to trigger protective immune responses and prepare the immune system to fight future infections from disease-causing agents. Vaccines stimulate the immune system’s production of antibodies that identify and destroy disease-causing organisms that enter the body. Vaccines provide immunity against one or several diseases that can lessen the severity or prevent certain diseases altogether.
Industry Insights

Due to the COVID-19 pandemic, the global Veterinary Vaccination market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, the Europe Veterinary Vaccination market is estimated at US$ million in 2022, while the United States and China are forecast to reach US$ million and US$ million by 2028, respectively. The proportion of the United States is % in 2022, while Chinese percentage is %, and it is predicted that China market share will reach % in 2028, trailing a CAGR of % through the analysis period. As for the Europe Veterinary Vaccination landscape, Germany is projected to reach US$ million by 2028. and in Asia, the notable markets are Japan and South Korea, CAGR is % and % respectively for the next 6-year period.

Live Attenuated Vaccines accounting for % of the Veterinary Vaccination global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Livestock segment is altered to an % CAGR throughout this forecast period and will hold a share about % in 2028.

The global major manufacturers of Veterinary Vaccination include Merck, Zoetis, Boehringer Ingelheim, Ceva, CAHIC, HVRI, Ringpu Biology, Yebio and DHN, etc. In terms of revenue, the global 3 largest players have a % market share of Veterinary Vaccination in 2021.

This report focuses on Veterinary Vaccination volume and value at the global level, regional level, and company level. From a global perspective, this report represents overall Veterinary Vaccination market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan, etc.

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Post-covid-19 Outlook

The readers in the section will understand how the Veterinary Vaccination market scenario changed across the globe during the pandemic and post-pandemic. The study is done keeping in view the changes in aspects such as sales, demand and supply chain. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Segmental Outlook

Key segments including type and application have been elaborated in this report. The consultants at QY Research have studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows sales and revenue data by type, and application during the historical period (2017-2022) and forecast period (2023-2028).

Segment by Type

Live Attenuated Vaccines

Inactivated Vaccines

Other

Segment by Application

Livestock

Swine

Chicken

Dog & Cat

Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue and sales data of each region and country for the period 2017-2028. This information derived through comprehensive research will help the reader to get familiar with the potential value of the investment in a particular region.

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Russia

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Indonesia

Thailand

Malaysia

Latin America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Competitive Scenario

In this section, the readers will gain an understanding of the key players competing. The experts at QY Research have studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

Merck

Zoetis

Boehringer Ingelheim

Ceva

CAHIC

HVRI

Ringpu Biology

Yebio

DHN

WINSUN

Elanco

Virbac

Jinyu Bio-Technology

ChengDu Tecbond

CAVAC

Kyoto Biken Laboratories

FATRO

Vaksindo

Bio-Labs

Avimex Animal Health

Frequently Asked Questions

Which product segment grabbed the largest share in the Veterinary Vaccination market?

How is the competitive scenario of the Veterinary Vaccination market?

Which are the key factors aiding the Veterinary Vaccination market growth?

Which are the prominent players in the Veterinary Vaccination market?

Which region holds the maximum share in the Veterinary Vaccination market?

What will be the CAGR of the Veterinary Vaccination market during the forecast period?

Which application segment emerged as the leading segment in the Veterinary Vaccination market?

What key trends are likely to emerge in the Veterinary Vaccination market in the coming years?

What will be the Veterinary Vaccination market size by 2028?

Which company held the largest share in the Veterinary Vaccination market?